메뉴 건너뛰기




Volumn 10, Issue 8, 2015, Pages

Likelihood of null effects of large NHLBI clinical trials has increased over time

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; HEALTH CARE COST; HEART DEATH; HEART PROTECTION; HUMAN; INTERVENTION STUDY; META ANALYSIS; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; CARDIOVASCULAR DISEASES; METHODOLOGY; PUBLISHING; REGISTER; TREATMENT OUTCOME; UNITED STATES;

EID: 84941992374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132382     Document Type: Article
Times cited : (218)

References (13)
  • 1
    • 84887437641 scopus 로고    scopus 로고
    • Publication of trials funded by the National Heart, Lung, and Blood Institute
    • 24224625
    • Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2013;369:1926-1934. doi: 10. 1056/NEJMsa1300237 PMID: 24224625
    • (2013) N Engl J Med. , vol.369 , pp. 1926-1934
    • Gordon, D.1    Taddei-Peters, W.2    Mascette, A.3    Antman, M.4    Kaufmann, P.G.5    Lauer, M.S.6
  • 4
    • 84906094329 scopus 로고    scopus 로고
    • Tracking the pharmaceutical pipeline: Clinical trials and global disease burden
    • 24816032
    • Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci 2014;7:297-299. doi: 10.1111/cts.12163 PMID: 24816032
    • (2014) Clin Transl Sci , vol.7 , pp. 297-299
    • Cottingham, M.D.1    Kalbaugh, C.A.2    Fisher, J.A.3
  • 5
    • 84925347795 scopus 로고    scopus 로고
    • Peering into the pharmaceutical "pipeline": Investigational drugs, clinical trials, and industry priorities
    • 25159693 Apr.
    • Fisher JA, Cottingham MD, Kalbaugh CA. Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities. Soc Sci Med. 2015 Apr; 131:322-330. doi: 10.1016/j. socscimed.2014.08.023 PMID: 25159693
    • (2015) Soc Sci Med. , vol.131 , pp. 322-330
    • Fisher, J.A.1    Cottingham, M.D.2    Kalbaugh, C.A.3
  • 6
    • 84928036813 scopus 로고    scopus 로고
    • Cardiovascular drug development: Is it dead or just hibernating?
    • 25881939
    • Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, et al. Cardiovascular drug development: is it dead or just hibernating? J Am Coll Cardiol. 2015;65:1567-1582. doi: 10.1016/j.jacc.2015.03.016 PMID: 25881939
    • (2015) J Am Coll Cardiol. , vol.65 , pp. 1567-1582
    • Fordyce, C.B.1    Roe, M.T.2    Ahmad, T.3    Libby, P.4    Borer, J.S.5    Hiatt, W.R.6
  • 7
    • 84903947419 scopus 로고    scopus 로고
    • Alzheimer's disease drug-development pipeline: Few candidates, frequent failures
    • 25024750
    • Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 2014;6:37. doi: 10.1186/alzrt269 PMID: 25024750
    • (2014) Alzheimers Res Ther , vol.6 , pp. 37
    • Cummings, J.L.1    Morstorf, T.2    Zhong, K.3
  • 9
    • 40449088049 scopus 로고    scopus 로고
    • Moving toward transparency of clinical trials
    • 18323436
    • Zarin DA, Tse T. Medicine. Moving toward transparency of clinical trials. Science 2008;319:1340-1342. doi: 10.1126/science.1153632 PMID: 18323436
    • (2008) Science , vol.319 , pp. 1340-1342
    • Zarin, D.A.1    Medicine, T.T.2
  • 10
    • 29544449337 scopus 로고    scopus 로고
    • Trial registration at ClinicalTrials.gov between May and October 2005
    • 16382064
    • Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;; 353:2779-2787. PMID: 16382064
    • (2005) N Engl J Med. , vol.353 , pp. 2779-2787
    • Zarin, D.A.1    Tse, T.2    Ide, N.C.3
  • 11
    • 79952267051 scopus 로고    scopus 로고
    • The ClinicalTrials.gov results database-update and key issues
    • 21366476
    • Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database-update and key issues. N Engl J Med. 2011;364:852-860. doi: 10.1056/NEJMsa1012065 PMID: 21366476
    • (2011) N Engl J Med. , vol.364 , pp. 852-860
    • Zarin, D.A.1    Tse, T.2    Williams, R.J.3    Califf, R.M.4    Ide, N.C.5
  • 12
    • 0035906308 scopus 로고    scopus 로고
    • The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
    • 11308435
    • Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-1991. PMID: 11308435
    • (2001) JAMA , vol.285 , pp. 1987-1991
    • Moher, D.1    Schulz, K.F.2    Altman, D.3
  • 13
    • 84900455772 scopus 로고    scopus 로고
    • Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: A modeling study
    • 24798522
    • Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, et al. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med 2014;160:594-602. doi: 10.7326/M13-2348 PMID: 24798522
    • (2014) Ann Intern Med , vol.160 , pp. 594-602
    • Roth, J.A.1    Etzioni, R.2    Waters, T.M.3    Pettinger, M.4    Rossouw, J.E.5    Anderson, G.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.